In addition, both the Thermographic Disease Activity Index (ThermoDAI) and Thermographic Disease Activity Index C-reactive protein (ThermoDAI-CRP) have shown construct validity and sensitivity to change, indicating their usefulness in assessing the disease activity and treatment response in patients with RA. This evidence concerns the gene CRP and rheumatoid arthritis.